Royal Bank of Canada
TNDM icon

Royal Bank of Canada’s Tandem Diabetes Care TNDM Stock Holding History

Royal Bank of Canada’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-100
Closed -$6K – 7179
2019
Q1 		$6K Hold
100
– – ﹤0.01% 6218
2018
Q4 		$4K Buy
+100
New +$3.53K ﹤0.01% 6254

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Royal Bank of Canada's TNDM Position: Q1 2026 in Review

Royal Bank of Canada reduced its Tandem Diabetes Care (TNDM) stake by 1.2% in Q1 2026, selling an estimated $54.2K and leaving 206,033 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #2594.

Royal Bank of Canada first reported a position in TNDM in Q2 2014 and has held it in 48 quarters since. The position peaked at $13.1M in Q2 2019. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Royal Bank of Canada held 206,033 shares of Tandem Diabetes Care worth $3.95M as of Q1 2026.
  • Royal Bank of Canada sold 2,495 Tandem Diabetes Care shares in Q1 2026, an estimated $54.2K.
  • Tandem Diabetes Care made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #2594 holding.
  • Royal Bank of Canada first reported a position in Tandem Diabetes Care in Q2 2014 and has held it in 48 quarters since.
  • Royal Bank of Canada's Tandem Diabetes Care position peaked at $13.1M in Q2 2019.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.